Effect of PK-guided tamoxifen dose escalation on endoxifen serum concentrations in CYP2D6 intermediate and poor metabolizers

Author(s):
Opdam, F.; Dezentje, V.O.; Hartigh, J. den; Guchelaar, H.J. (0000-0002-7085-1383); Hessing, T.; Straaten, T. van der; Vree, R.; Batman, E.; Maartense, E.; Smorenburg, C.H.; Zeillemaker, A.; Brakenhoff, J.A.C.; ; Kuijer, P.; Putter, H.; Dieudonne, A.S.; Maven, P.; Velde, C.J.H. van de (0000-0003-0104-1800); Nortier, J.W.R.; Gelderblom, H.
Published
2013
Publication type
Article / Letter to editor
Date issued
2013-05-20
Language
English
Is part of
Journal of Clinical Oncology (2013), No. 15
hdl
1887/104670